The overall sentiment reflects strong agreement and high interest, evidenced by references to scientific papers, mentions of bacteria like Akkermansia, and discussions about how the microbiome may improve immunotherapy outcomes. Word choices such as 'science shows,' 'important,' and 'game changer' indicate both engagement and perceived significance, which contributes to the high scores across all categories.
AgreementModerate agreement
Most discussions support the idea that the microbiome significantly affects immunotherapy outcomes, with many citing prior research and emphasizing the relevance.
InterestHigh interest
Posts show high curiosity and enthusiasm, referencing specific bacteria like Akkermansia muciniphila and discussing potential for improving treatment success.
EngagementHigh engagement
Many discussions provide detailed insights, citing studies, mechanisms, and implications, demonstrating deep involvement.
ImpactHigh impact
The emphasis on scientific findings, references to major studies, and implications for cancer treatment highlight a belief that this research could influence clinical practices.
Abstract in brief
The gut microbiome plays a crucial role in determining the effectiveness of PD1-based immunotherapy for epithelial tumors, with abnormalities in microbiome composition linked to primary resistance to treatment.
Antibiotic use can reduce the clinical benefits of immune checkpoint inhibitors in cancer patients, suggesting that healthy gut bacteria are important for therapy success.
Fecal microbiota transplantation (FMT) from responders to non-responders can improve immunotherapy outcomes by enhancing immune responses, especially when combined with oral supplementation that boosts interleukin-12 and T cell recruitment to tumors.
@anguspratt @StephenVLiu @JTOonline There is work assessing the gut microbiome & ICI outcomes in NSCLC, led by @derosa__lisa @BertrandRouty: https://t.co/hWc0wL9IoM
https://t.co/7sLpbvk0Gy
https://t.co/zyZ11iJPAn
Also, on the lung microbiota in NSCLC @nyuniversity w our own @amgodogma: https://t.co/wf6plG7KY9
Feb 13, 2023 · 6 likes · 11,478 followersView post →
바
바이오매니아
@microviolist · X
이미 2018년도에 면역항암제가 잘 듣는 사람들에게 장내미생물이 중요한 역할을 하는 것 같고 그 중 Akkermansia muciniphila라는 종이 중요한 역할을 하는 것 같다는 논문이 사이언스에 실렸었죠. 그래서 애커맨시아 연구들이 흥했는데, 이번엔 아예 하나의 균을 특정했고
https://t.co/jDkOM7Crqa
2/18. @BertrandRouty and colleagues showed that antibiotics compromise the efficacy of PD-1 blockade in @ScienceMagazine https://t.co/yF617KwxTw
➡️ But is there a role for specific bacteria? https://t.co/PaOPL0Hrh9
Discover groundbreaking research on how gut bacteria influence immunotherapy success and how diet and microbiome health can help prevent and fight cancer. Learn about therapies like fecal transplants and foods that…
This episode features Dr Gianluca Ianiro MD PhD discussing advances in gut microbiome testing for medical use, emphasizing the need for standardization to improve clinical utility and outcomes in therapies like FMT and…
이미 2018년도에 면역항암제가 잘 듣는 사람들에게 장내미생물이 중요한 역할을 하는 것 같고 그 중 Akkermansia muciniphila라는 종이 중요한 역할을 하는 것 같다는 논문이 사이언스에 실렸었죠. 그래서 애커맨시아 연구들이 흥했는데, 이번엔 아예 하나의 균을 특정했고
https://t.co/jDkOM7Crqa
2/18. @BertrandRouty and colleagues showed that antibiotics compromise the efficacy of PD-1 blockade in @ScienceMagazine https://t.co/yF617KwxTw
➡️ But is there a role for specific bacteria? https://t.co/PaOPL0Hrh9
@Oliviersanstom @TheRealZeRoY @raoult_didier Science
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
cité par +3000 chercheurs
@anguspratt @StephenVLiu @JTOonline There is work assessing the gut microbiome & ICI outcomes in NSCLC, led by @derosa__lisa @BertrandRouty: https://t.co/hWc0wL9IoM
https://t.co/7sLpbvk0Gy
https://t.co/zyZ11iJPAn
Also, on the lung microbiota in NSCLC @nyuniversity w our own @amgodogma: https://t.co/wf6plG7KY9
Feb 13, 2023 · 6 likes · 11,478 followersView post →
MM
Madam Mitochondria
@Madam_Mito · X
@exosome @StevenMetaverse https://t.co/N8N3Mp3nZW Akkermansia M. Again. I’ll stop, it’s just so cool.
Jan 8, 2023 · 1 like · 10,895 followersView post →
MO
Molecular Oncology
@MolOncology · X
Gut microbiome influence efficacy of PD-1 based immunotherapy against epithelial tumours
https://t.co/S2STF0gR68
6/ These findings add to prior studies – e.g. also @ScienceMagazine – re. the role of the #microbiome in clinical outcomes in cancer patients:
– Epithelial tumors, nonresponders had ⬇️ levels of Akkermansia muciniphila https://t.co/eeKiXPfu1W
– Melanoma:
https://t.co/gxxpXUoSj5
Dec 26, 2021 · 1 share · 3,115 followersView post →
Y
YodaTheThird
@DrissAyadi2 · X
@LeptOBDS @EvskyLeman @aartkaa @OMariano0 @raoult_didier Mais oui bien sûr les fameuses revues prédatrices que sont Science et AMS https://t.co/D8xu6LkYLY https://t.co/B8zOf5eWcC
https://t.co/UdPSYaS2PE
The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients https://t.co/ktiE6QUjQk
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors https://t.co/ob7TP68QKk
Wellness Center Massage (@PagelandMassage) • Facebook
Facebook
DOI: 10.1126/science.aan3706 • Summary: Higher abundance of A. muciniphila linked to better overall survival and treatment response in cancer patients receiving ...
... Science, 2018. DOI: 10.1126/science.aan3706 ✓ Higher abundance of A. muciniphila = better survival + response to treatment in cancer patients You don't ...
DOI: 10.1126/science.aan3706 (Studie 1). DOI: 10.1126/science.aan4236 (Studie 2). Mehr zum Thema Krebs und Zytostatika. 03.11.2017 l PZ. Foto: Fotolia/ ...
DOI: 10.1126/science.aan3706 ✓ Higher abundance of A. muciniphila = better survival + response to treatment in cancer patients You don't need a miracle pill— ...
Microbiome-derived inosine modulates response to checkpoint ...
News
Science 359, 91–97 (2018). doi:10.1126/science.aan3706 Medline. 9. V. Matson, J. Fessler, R. Bao, T. Chongsuwat, Y. Zha, M.-L. Alegre, J. J. Luke, T. F..
The science and medicine of human immunology | Science
News
AnywhereScienceScience AdvancesScience ImmunologyScience RoboticsScience SignalingScience Translational Medicine ... 10.1126/science.aan3706. GO TO REFERENCE.
Unveiling Gut Microbes' Influence on Cancer Patient Response to ...
News
American Association for the Advancement of Science (AAAS). Journal: Science; DOI: 10.1126/science.aan3706. Keywords. /Health and medicine/Clinical medicine ...
Gut microbiome influences efficacy of PD-1–based immunotherapy ...
News
Routy et al., Science. 10.1126/science.aan3706 (2017). First release: 2 November 2017 www.sciencemag.org. (Page numbers not final at time of first release) 1 ...
Gut microbiome influences efficacy of PD-1–based immunotherapy ...
News
Science. 2 Nov 2017. Vol 359, Issue 6371. pp. 91-97. DOI: 10.1126/science.aan3706 · PREVIOUS ARTICLE. Elevated HLA-A expression impairs HIV control through ...